ChartRow logo
Data provided bySource: Twelve Data
BAX
$25.79+0.55%
as of close, Nov 6, 2026
☾ AH $25.79 +0.55%
PeersGEHCELANSOLVCOOALGNHLN
Share this page

BAX — Baxter International price, chart and key statistics

Technical analysis2
Overlay lines0
Addendum charts0
Data provided bySource: Twelve Data
What would $1,000 invested in BAX be worth today? →
BAX returns: By year · By month · By week · Trailing

Price data

Price
$25.79
YTD price return
+34.96%
YTD total return
+35.14%
Market cap
13.3B
Enterprise value
21.9B
Shares outstanding
517.3M
52W low
$15.73
52W high
$30.00
From 52W high
-14.03%
From 52W low
+63.95%
52W range
70%$15.73–$30.00
Beta
0.59

Volume

Rel volume
0.86×
30D volume
7.2M
30D $ vol
178M

Fundamentals

Sales (ttm)
11.6B
Sales/share
$22.44
EPS (ttm)
-$1.40
FCF (ttm)
1.1B
FCF/share
$2.20
Book value/share
$12.57
Net margin
-6.23%
ROE
-11.12%
ROA
-3.72%
Debt / equity
1.45×
Current ratio
1.79

Growth (CAGR, ttm) · 10Y

Sales
+5.34%+4.23%-1.39%+1.38%
FCF
+366.48%-4.60%-5.34%+2.07%
Shares
+0.64%+0.65%+0.66%-0.50%

Per-share growth (CAGR, ttm) · 10Y

Sales/share
+4.67%+3.53%-2.03%+1.89%
FCF/share
+363.50%-5.24%-5.96%+2.59%
Book value/share
-10.78%-7.67%-6.42%-2.36%
Dividend/share
-94.13%-67.44%-47.98%-22.17%
Price
+43.47%-9.23%-19.86%-5.82%
Total return
+43.75%-7.53%-18.27%-4.36%

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)
-18.4×
P/OI (ttm)
1233.4×
Fwd P/E
12.6×
P/S (ttm)
1.1×
P/B (mrq)
2.1×
P/FCF (ttm)
11.7×
EV/EBITDA (fy)
29.9×
EV/Sales (ttm)
1.9×
FCF yield (ttm)
8.52%
Dividend yield (fwd)Div yield
0.16%
Dividend yield (ttm)
0.16%
Dividend/share (fwd)
$0.04
Buyback yield (realized, 1y)
-0.64%
Shareholder yield (realized, 1y)
0.23%
Buyback yield (cash, ttm)
0.00%
Shareholder yield (cash, ttm)
0.76%

Vs own 10Y history

P/E
96th
P/OI
99th
P/S
13th
P/B
14th
P/FCF
1st

Bar = where today’s multiple sits in BAX’s own 10-year range:near a decade-low (cheap)→mid-range→near a decade-high (rich).

Performance · price returntotal return · as of 2026-11-06#

Data provided bySource: Twelve Data
1D
+0.55%
5D
+12.13%
1M
+5.87%
3M
-4.52%
YTD
+34.96%
1Y
+43.44%
5Y
-66.95%
1D
+0.55%
5D
+12.13%
1M
+5.87%
3M
-4.48%
YTD
+35.14%
1Y
+43.71%
5Y
-63.55%

Fundamentals#

Revenue

5Y CAGR −0.7%10Y CAGR +1.2%YoY +5.0%
$11.6B TTM$3B Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Operating income

5Y n/m10Y n/mYoY +30.8%
−$221M TTM$225M Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

EPS (diluted)

5Y n/m10Y n/mYoY n/m
−$1.40 TTM$0.57 Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Free cash flow

5Y CAGR −22.1%10Y CAGR −9.1%YoY +255.6%
$1.1B TTM$448M Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM

TTM: operating cash flow $1.6B, capex −$503M

Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Q3 2026: operating cash flow $558M, capex −$110M

Shares (diluted)

5Y −0.8%10Y −6.6%YoY +1.2%
515.8M TTM520M Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Dividend per share

5Y CAGR −11.4%10Y CAGR −8.5%YoY −94.1%
$0.04 TTM$0.01 Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Full BAX financials →

About Baxter International#

Data provided bySource: Twelve Data

Baxter International Inc. is a global healthcare company focused on providing essential medical products and technologies used in hospitals, clinics, surgery centers, pharmacies, and home-care settings. Baxter International Inc. develops and supplies infusion systems, sterile intravenous solutions, injectable pharmaceuticals, parenteral nutrition therapies, advanced surgery products, patient monitoring and diagnostic technologies, smart beds, and respiratory care devices. The company also supports renal and acute care through therapies and connected solutions that help clinicians deliver treatment across a wide range of care environments. Its portfolio is designed to support everyday healthcare delivery, from critical care and procedural settings to long-term and ambulatory care. Baxter International Inc. plays an important role in the medical technology market by supplying products that are widely used in routine treatment, life-sustaining therapy, and hospital infrastructure.

Deerfield, IL·37,500 employees·Medical Instruments & Supplies·baxter.com·As of Oct 28, 2026

Recent filings#

All filings and insider trades →

ETFs holding BAX#

28 of the 193 ETFs ChartRow carries live hold BAX. The 8 largest positions, by the weight each fund filed in its latest SEC N-PORT report (Jun 26 to Aug 26).

FundNameFiled weight
RSPInvesco S&P 500 Equal Weight ETF0.2%
VBRVanguard Small-Cap Value ETF0.2%
XLVHealth Care Select Sector SPDR Fund0.2%
VHTVanguard Health Care ETF0.2%
VBVanguard Small-Cap ETF0.1%
IWSiShares Russell Mid-Cap Value ETF0.1%
IWRiShares Russell Midcap ETF0.1%
VYMVanguard High Dividend Yield ETF0.1%
TickerName1M1D
LLYEli Lilly and Company+16.98%-0.79%
JNJJohnson & Johnson+8.42%+1.43%
ABBVAbbVie Inc.+9.23%+1.07%
MRKMerck & Co. Inc.+3.37%-0.14%
UNHUnitedHealth Group Incorporated Common Stock (DE)+4.74%-0.40%
NVSNovartis AG+15.46%+0.38%
TMOThermo Fisher Scientific Inc.+5.81%+2.63%
AMGNAmgen Inc.+14.36%+0.03%